share_log

Morgan Stanley Maintains Overweight on United Therapeutics, Lowers Price Target to $314

Benzinga ·  Nov 2, 2023 15:19

Morgan Stanley analyst Terence Flynn maintains United Therapeutics (NASDAQ:UTHR) with a Overweight and lowers the price target from $318 to $314.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment